` IBAB (Ion Beam Applications SA) vs DAX Index Comparison - Alpha Spread

IBAB
vs
DAX Index

Over the past 12 months, IBAB has underperformed DAX Index, delivering a return of -15% compared to the DAX Index's 29% growth.

Stocks Performance
IBAB vs DAX Index

Loading
IBAB
DAX Index
Add Stock
www.alphaspread.com

Performance Gap
IBAB vs DAX Index

Loading
IBAB
DAX Index
Difference
www.alphaspread.com

Performance By Year
IBAB vs DAX Index

Loading
IBAB
DAX Index
Add Stock

Competitors Performance
Ion Beam Applications SA vs Peers

DAX Index
IBAB
ABT
ISRG
BSX
SYK
Add Stock

Ion Beam Applications SA
Glance View

Market Cap
355.1m EUR
Industry
Health Care

Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

IBAB Intrinsic Value
22.89 EUR
Undervaluation 47%
Intrinsic Value
Price
Back to Top